Pazopanib for second recurrence of osteosarcoma in pediatric patients
Pazopanib for second recurrence of osteosarcoma in pediatric patients
复制标题
DOI：
10.1111/ped.13307
复制
发表时间：
2017-08-01
影响因子：
1.4
通讯作者：
Adachi, Souchi
中科院分区：
文献类型：
--
作者：
Umeda, Katsutsugu;Kato, Itaru;Adachi, Souchi
本文介绍了帕佐帕尼治疗儿童骨肉瘤(OS)二次复发的病例。讨论的主题包括观察血清碱性磷酸酶(ALP)的升高；借助计算机断层扫描(CT)检测肝内肿瘤大小的NO变化；以及与帕佐帕尼相关的不良反应的信息。
The article presents cases of pediatric patients with osteosarcoma (OS) treated with pazopanib for second recurrence. Topics discussed include observation of the elevated serum alkaline phosphatase (ALP); detection of no changes in the size of intrahepatic tumors with the help of computed tomography (CT); and information on adverse effects associated with pazopanib.